| - GRCh37:
- Chr2:88748276
- GRCh38:
- Chr2:88448757
| FOXI3 | R238Q | Goldenhar syndrome | Likely pathogenic (Mar 6, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr2:88747746
- GRCh38:
- Chr2:88448227
| FOXI3 | R415* | Goldenhar syndrome | Likely pathogenic (Mar 6, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr2:88748286
- GRCh38:
- Chr2:88448767
| FOXI3 | R235C | Goldenhar syndrome | Likely pathogenic (Mar 6, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr2:88747861-88747872
- GRCh38:
- Chr2:88448342-88448353
| FOXI3 | | not provided | Uncertain significance (Dec 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr4:186473718-187912600
| KLKB1, TLR3, F11, FAM149A, FAT1, MTNR1A, SORBS2, CYP4V2 | | Goldenhar syndrome | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr1:53237123
- GRCh38:
- Chr1:52771451
| ZYG11B | R210* | Goldenhar syndrome | Likely pathogenic (May 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:88748270
- GRCh38:
- Chr2:88448751
| FOXI3 | R240H | not provided | Uncertain significance (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:65835667-65835668
- GRCh38:
- Chr11:66068196-66068197
| SF3B2 | L828fs | Goldenhar syndrome | Pathogenic (Jul 13, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr11:65819856
- GRCh38:
- Chr11:66052385
| SF3B2 | M1L | Goldenhar syndrome | Pathogenic (Jul 13, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr11:65829404
- GRCh38:
- Chr11:66061933
| SF3B2 | R638* | Goldenhar syndrome | Pathogenic (Jul 13, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr11:65829155
- GRCh38:
- Chr11:66061684
| SF3B2 | | Goldenhar syndrome | Pathogenic (Jul 13, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr6:116289885
- GRCh38:
- Chr6:115968722
| FRK | V162I | Goldenhar syndrome | Uncertain significance (May 10, 2021) | no assertion criteria provided |